Key result
Poorer metabolite-based myocardial-vascular health scores linked to higher incident CVD risk in young adults.
Why the study?
CVD metrics define risk in individuals >40 years of age despite lesions appearing earlier, and studies in younger, biracial populations to define precise metabolic risk phenotypes are lacking.
Do metabolite-based risk scores predict incident cardiovascular disease in young adults?
Cohort (n=2,330)
Yes
Do metabolite-based risk scores predict incident cardiovascular disease in young adults?
Metabolic profiling in young adults identifies signatures of myocardial and vascular health that predict future cardiovascular disease over two decades.
Answers are grounded in this paper and cite their sources.
May support early metabolite-based CVD risk assessment in young adults; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND: Whereas cardiovascular disease (CVD) metrics define risk in individuals >40 years of age, the earliest lesions of CVD appear well before this age. Despite the role of metabolism in CVD antecedents, studies in younger, biracial populations to define precise metabolic risk phenotypes are lacking. METHODS: We studied 2330 White and Black young adults (mean age, 32 years; 45% Black) in the CARDIA study (Coronary Artery Risk Development in Young Adults) to identify metabolite profiles associated with an adverse CVD phenome (myocardial structure/function, fitness, vascular calcification), mechanisms, and outcomes over 2 decades. Statistical learning methods (elastic nets/principal components analysis) and Cox regression generated parsimonious, metabolite-based risk scores validated in >1800 individuals in the Framingham Heart Study. RESULTS: =0.0004 for a combined myocardial-vascular score with incident CVD), such that young adults with poorer metabolite-based health scores had highest hazard of future CVD. CONCLUSIONS: Metabolic signatures of myocardial and vascular health in young adulthood specify known/novel pathways of metabolic dysfunction relevant to CVD, associated with outcome in 2 independent cohorts. Efforts to include precision measures of metabolic health in risk stratification to interrupt CVD at its earliest stage are warranted.
No takes yet. Share an insight, caveat, or question.
Murthy et al. (2020) conducted a cohort in Cardiovascular disease risk in young adults (n=2,330). Metabolite-based myocardial and vascular health scores vs. Favorable metabolite-based health scores was evaluated on Incident cardiovascular disease (CVD) and adverse CVD phenome (myocardial structure/function, fitness, vascular calcification) (p=0.0004). Poorer metabolite-based myocardial-vascular health scores in young adults were associated with a higher hazard of incident cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: